» Articles » PMID: 26630317

SYSTEMIC RISK FACTORS IN BILATERAL PROLIFERATIVE DIABETIC RETINOPATHY REQUIRING VITRECTOMY

Overview
Journal Retina
Date 2015 Dec 3
PMID 26630317
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The visual outcome after vitrectomy for proliferative diabetic retinopathy (PDR) is often poor. Bilateral vitrectomy has been especially associated with a poor visual prognosis in patients with PDR. The authors investigated the systemic risk factors for PDR requiring bilateral vitrectomy compared with unilateral vitrectomy.

Methods: The authors retrospectively reviewed 86 consecutive patients with Type 2 diabetes mellitus with PDR who underwent vitrectomy. These patients were divided into 2 groups: bilateral vitrectomy within 1 year (n = 25) and unilateral vitrectomy (n = 61). The authors compared the systemic risk factors: age, sex, duration of diabetes, hemoglobin A1c, body mass index, estimated glomerular filtration rate, uric albumin, hypertension, dyslipidemia, history of ischemic heart disease, arteriosclerosis obliterans, and smoking.

Results: There were significantly more cases with severe renal dysfunction in the bilateral vitrectomy group compared with the unilateral one (estimated glomerular filtration rate <30 mL/minute/1.73 m; bilateral cases = 5/25; unilateral cases = 2/61; P = 0.02).

Conclusion: The authors found that severe renal dysfunction may be a risk factor in PDR requiring bilateral vitrectomy, indicating that careful attention needs to be paid to prevent the progression of diabetic retinopathy to severe PDR in the other eye if patients have severe unilateral PDR and severe renal dysfunction.

Citing Articles

Bilateral vitrectomy in patients with proliferative diabetic retinopathy-characteristics and surgical outcomes.

Hsia Y, Yang C Graefes Arch Clin Exp Ophthalmol. 2024; 262(9):2833-2844.

PMID: 38578330 DOI: 10.1007/s00417-024-06462-5.


Renal impairment may indicate postoperative low vision in young patients with proliferative diabetic retinopathy undergoing vitrectomy.

Zheng X, Feng L, Xing C, Wang J, Zhao W, Zhang F Front Endocrinol (Lausanne). 2024; 14:1321226.

PMID: 38274226 PMC: 10808762. DOI: 10.3389/fendo.2023.1321226.


Establishment and validation of a prognostic nomogram for long-term low vision after diabetic vitrectomy.

Guo H, Wang Z, Nie Z, Zhang X, Wang K, Duan N Front Endocrinol (Lausanne). 2023; 14:1196335.

PMID: 37693349 PMC: 10485701. DOI: 10.3389/fendo.2023.1196335.


Diabetic retinopathy: emerging concepts of current and potential therapy.

Sadikan M, Abdul Nasir N Naunyn Schmiedebergs Arch Pharmacol. 2023; 396(12):3395-3406.

PMID: 37401966 DOI: 10.1007/s00210-023-02599-y.


Relationship between renal function and prognosis of Chinese proliferative diabetic retinopathy patients undergoing the first vitrectomy: protocol for a prospective cohort study.

Lei C, Zhang K, Chang T, Ran Q, Zhang M BMJ Open. 2021; 11(12):e052417.

PMID: 34873003 PMC: 8650473. DOI: 10.1136/bmjopen-2021-052417.